Reference 2021-36

REF: 2021-36          

Subject: Biologic and biosimilar products      

 

Request:

Q1. Could you please provide the numbers of patients treated by the rheumatology department (for any condition) in the last 3 months with the following drugs:

  • Abatacept [Orencia]
  • Adalimumab [Humira]
  • AdalimumabBiosimilars
  • Apremilast [Otezla]
  • Baricitinib [Olumiant]
  • Certolizumab [Cimzia]
  • Etanercept [Enbrel]
  • EtanerceptBiosimilars
  • Filgotinib [Jyseleca]
  • Golimumab [Simponi]
  • Infliximab [Remicade]
  • Infliximab Biosimilars
  • Ixekizumab [Taltz]
  • Rituximab [MabThera]
  • Rituximab Biosimilars
  • Sarilumab [Kevzara]
  • Secukinumab [Cosentyx]
  • Tocilizumab [Ro Actemra]
  • Tofacitinib [Xeljanz]
  • Upadacitinib [Rinvoq]
  • Ustekinumab [Stelara]

Q2. Could you please provide the numbers of patients treated for Psoriatic Arthritis ONLY in the last 3 months with the following drugs.

  • Abatacept [Orencia]
  • Adalimumab [Humira]
  • AdalimumabBiosimilars
  • Apremilast [Otezla]
  • Certolizumab [Cimzia]
  • Etanercept [Enbrel]
  • EtanerceptBiosimilars
  • Golimumab [Simponi]
  • Guselkumab [Tremfya]
  • Infliximab [Remicade]
  • Infliximab Biosimilars
  • Ixekizumab [Taltz]
  • Secukinumab [Cosentyx]
  • Tofacitinib [Xeljanz]
  • Ustekinumab [Stelara]

 

 

Response:

Q1. Could you please provide the numbers of patients treated by the rheumatology department (for any condition) in the last 3 months with the following drugs:
Abatacept [Orencia] 28
Adalimumab [Humira] 15
AdalimumabBiosimilars 164
Apremilast [Otezla] 7
Baricitinib [Olumiant] 12
Certolizumab [Cimzia] 33
Etanercept [Enbrel] 12
EtanerceptBiosimilars 115
Filgotinib [Jyseleca] 0
Golimumab [Simponi] 12
Infliximab [Remicade] 0
Infliximab Biosimilars 0
Ixekizumab [Taltz] 0
Rituximab [MabThera] 4
Rituximab Biosimilars 10
Sarilumab [Kevzara] 0
Secukinumab [Cosentyx] 8
Tocilizumab [Ro Actemra] 35
Tofacitinib [Xeljanz] 1
Upadacitinib [Rinvoq] 0
Ustekinumab [Stelara] 0
Q2. Could you please provide the numbers of patients treated for Psoriatic Arthritis ONLY in the last 3 months with the following drugs.
Abatacept [Orencia] Do not hold this information
Adalimumab [Humira]
AdalimumabBiosimilars
Apremilast [Otezla]
Certolizumab [Cimzia]
Etanercept [Enbrel]
EtanerceptBiosimilars
Golimumab [Simponi]
Guselkumab [Tremfya]
Infliximab [Remicade]
Infliximab Biosimilars
Ixekizumab [Taltz]
Secukinumab [Cosentyx]
Tofacitinib [Xeljanz]
Ustekinumab [Stelara]